Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
ContributorsNash, Peter; Kerschbaumer, Andreas; Dörner, Thomas; Dougados, Maxime; Fleischmann, Roy M; Geissler, Klaus; McInnes, Iain; Pope, Janet E; van der Heijde, Désirée; Stoffer-Marx, Michaela; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin L; de Wit, Maarten; Aletaha, Daniel; Baraliakos, Xenofon; Boehncke, Wolf-Henning; Emery, Paul; Isaacs, John D; Kremer, Joel; Lee, Eun Bong; Maksymowych, Walter P; Voshaar, Marieke; Tam, Lai-Shan; Tanaka, Yoshiya; van den Bosch, Filip; Westhovens, René; Xavier, Ricardo; Smolen, Josef S
Published inAnnals of the Rheumatic Diseases, vol. 80, no. 1, p. 71-87
Publication date2021
Abstract
Keywords
- Adamantane/analogs & derivatives/therapeutic use
- Advisory Committees
- Antirheumatic Agents/therapeutic use
- Arthritis
- Psoriatic/drug therapy/immunology
- Arthritis
- Rheumatoid/drug therapy/immunology
- Azetidines/therapeutic use
- Cytokines/immunology
- Drug Therapy
- Combination
- Europe
- Heterocyclic Compounds
- 3-Ring/therapeutic use
- Humans
- Inflammatory Bowel Diseases/drug therapy/immunology
- Janus Kinase Inhibitors/therapeutic use
- Niacinamide/analogs & derivatives/therapeutic use
- Piperidines/therapeutic use
- Psoriasis/drug therapy/immunology
- Purines/therapeutic use
- Pyrazoles/therapeutic use
- Pyridines/therapeutic use
- Pyrimidines/therapeutic use
- Rheumatology
- Spondylarthropathies/drug therapy/immunology
- Spondylitis
- Ankylosing/drug therapy/immunology
- Sulfonamides/therapeutic use
- Triazoles/therapeutic use
Affiliation
Research group
Citation (ISO format)
NASH, Peter et al. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. In: Annals of the Rheumatic Diseases, 2021, vol. 80, n° 1, p. 71–87. doi: 10.1136/annrheumdis-2020-218398
Main files (1)
Article (Published version)
Identifiers
- PID : unige:154811
- DOI : 10.1136/annrheumdis-2020-218398
- PMID : 33158881
Commercial URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788060/
ISSN of the journal0003-4967
